🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to access the safety and efficacy of neoadjuva...
Status
Unknown
Location
Min Jin
Start Date
2021-03-30
Trial ID
NCT06250894
Treatments Being Tested
This study is for patients with locally advanced pancreatic cancer (cancer ...
Status
Unknown
Location
Columbia University Medical Center
Start Date
2009-12
Trial ID
NCT01065870
This is a multicenter, single-arm, phase II study of nivolumab in combinati...
Status
Active Not Recruiting
Location
Institut Jules Bordet
Start Date
2021-03-25
Trial ID
NCT04503694
The purpose of this study is to test the effectiveness of a home-based, pat...
Status
Completed
Location
Northwestern University
Start Date
2021-12-10
Trial ID
NCT05092763
Treatments Being Tested
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
To explore the efficacy and safety of an intensified treatment regimen cons...
Status
Recruiting
Location
Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2026-05-20
Trial ID
NCT07549399
To learn if giving elranatamab before and after an autologous stem cell tra...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-07-17
Trial ID
NCT06207799
Treatments Being Tested
Exploratory study on blood-borne biological markers and their correlation w...
Status
Completed
Location
Centre Georges François Leclerc
Start Date
2015-07
Trial ID
NCT02866149
Treatments Being Tested
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
This is a Phase II single-arm study designed to evaluate the efficacy and s...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-04-01
Trial ID
NCT06939127